.png)
Inflammatory Bowel Disease Therapy Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 164 Category: Pharma & Healthcare Report Code : HC0316586
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Inflammatory Bowel Disease Therapy Market By Type (TNF Inhibitors, Aminosalicylates) and Application (Hospital, Pharmacy)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Inflammatory Bowel Disease Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. The aim of inflammatory bowel disease treatment is to reduce the inflammation that triggers your signs and symptoms. IBD treatment usually involves either drug therapy or surgery.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Inflammatory Bowel Disease Therapy Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott Laboratories
- Valeant Pharmaceuticals International
- Novartis AG
- Janssen Biotech, Inc.
- Alkem Laboratories Limited
- AbbVie, Inc.
- UCB Inc
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Pfizer Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Inflammatory Bowel Disease Therapy Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o TNF Inhibitors
o Aminosalicylates
· Inflammatory Bowel Disease Therapy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Pharmacy
· Inflammatory Bowel Disease Therapy Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott Laboratories
o Valeant Pharmaceuticals International
o Novartis AG
o Janssen Biotech, Inc.
o Alkem Laboratories Limited
o AbbVie, Inc.
o UCB Inc
o Takeda Pharmaceutical Company Limited
o Biogen Inc.
o Pfizer Inc.
· Inflammatory Bowel Disease Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Inflammatory Bowel Disease Therapy Market, By Country
o U.S. Inflammatory Bowel Disease Therapy Market
o Canada Inflammatory Bowel Disease Therapy Market
o Mexico Inflammatory Bowel Disease Therapy Market
o Europe
§ Europe Inflammatory Bowel Disease Therapy Market, By Country
o UK Inflammatory Bowel Disease Therapy Market
o Germany Inflammatory Bowel Disease Therapy Market
o France Inflammatory Bowel Disease Therapy Market
o Russia Inflammatory Bowel Disease Therapy Market
o Italy Inflammatory Bowel Disease Therapy Market
o Rest of Europe Inflammatory Bowel Disease Therapy Market
o Asia-Pacific
§ Asia-Pacific Inflammatory Bowel Disease Therapy Market, By Country
o China Inflammatory Bowel Disease Therapy Market
o Japan Inflammatory Bowel Disease Therapy Market
o South Korea Inflammatory Bowel Disease Therapy Market
o India Inflammatory Bowel Disease Therapy Market
o Southeast Asia Inflammatory Bowel Disease Therapy Market
o Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Market
o South America
§ South America Inflammatory Bowel Disease Therapy Market
o Brazil Inflammatory Bowel Disease Therapy Market
o Argentina Inflammatory Bowel Disease Therapy Market
o Columbia Inflammatory Bowel Disease Therapy Market
o Rest of South America Inflammatory Bowel Disease Therapy Market
o Middle East and Africa
§ Middle East and Africa Inflammatory Bowel Disease Therapy Market
o Saudi Arabia Inflammatory Bowel Disease Therapy Market
o UAE Inflammatory Bowel Disease Therapy Market
o Egypt Inflammatory Bowel Disease Therapy Market
o Nigeria Inflammatory Bowel Disease Therapy Market
o South Africa Inflammatory Bowel Disease Therapy Market
o Turkey Inflammatory Bowel Disease Therapy Market
o Rest of MEA Inflammatory Bowel Disease Therapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Inflammatory Bowel Disease Therapy Market, By Type
5.1. Introduction
5.2. Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Type (2017-2021)
5.2.1. Global Inflammatory Bowel Disease Therapy Revenue and Revenue Share by Type (2017-2021)
5.3. TNF Inhibitors
5.3.1. Global TNF Inhibitors Revenue and Growth Rate (2017-2021)
5.4. Aminosalicylates
5.4.1. Global Aminosalicylates Revenue and Growth Rate (2017-2021)
6. Inflammatory Bowel Disease Therapy Market, By Applications
6.1. Introduction
6.2. Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Inflammatory Bowel Disease Therapy Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2021)
6.4. Pharmacy
6.4.1. Global Pharmacy Revenue and Growth Rate (2017-2021)
7. Inflammatory Bowel Disease Therapy Market, By Region
7.1. Introduction
7.2. Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Regions
7.2.1. Global Inflammatory Bowel Disease Therapy Revenue by Regions (2017-2021)
7.3. North America Inflammatory Bowel Disease Therapy by Countries
7.3.1. North America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2021)
7.3.2. North America Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Inflammatory Bowel Disease Therapy by Countries
7.4.1. Europe Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2021)
7.4.2. Europe Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Inflammatory Bowel Disease Therapy by Countries
7.5.1. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Inflammatory Bowel Disease Therapy by Countries
7.6.1. South America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2021)
7.6.2. South America Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Inflammatory Bowel Disease Therapy by Countries
7.7.1. Middle East and Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Valeant Pharmaceuticals International
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Novartis AG
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Janssen Biotech, Inc.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Alkem Laboratories Limited
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. AbbVie, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. UCB Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Takeda Pharmaceutical Company Limited
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Biogen Inc.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Pfizer Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.1. Global Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Inflammatory Bowel Disease Therapy Market Forecast by Regions (2022-2027)
9.2.1. North America Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.1.1. United States Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.1.2. Canada Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.1.3. Mexico Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2. Europe Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.1. Germany Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.2. France Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.3. UK Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.4. Russia Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.5. Italy Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3. Asia-Pacific Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.1. China Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.2. Japan Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.3. Korea Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.4. India Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.4. South America Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.4.1. Brazil Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.4.2. Argentina Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.4.3. Columbia Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.4.4. Rest of South America Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5. Middle East and Africa Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.3. Egypt Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.4. Nigeria Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.5. South Africa Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.6. Turkey Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Market Forecast (2022-2027)
9.3. Inflammatory Bowel Disease Therapy Market Forecast by Type (2022-2027)
9.3.1. Inflammatory Bowel Disease Therapy Forecast by Type (2022-2027)
9.3.2. Inflammatory Bowel Disease Therapy Market Share Forecast by Type (2022-2027)
9.4. Inflammatory Bowel Disease Therapy Market Forecast by Applications (2022-2027)
9.4.1. Inflammatory Bowel Disease Therapy Forecast by Applications (2022-2027)
9.4.2. Inflammatory Bowel Disease Therapy Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Inflammatory Bowel Disease Therapy Revenue and Revenue Share by Type (2017-2019)
Figure Global TNF Inhibitors Revenue and Growth Rate (2017-2019)
Figure Global Aminosalicylates Revenue and Growth Rate (2017-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospital Revenue and Growth Rate (2017-2019)
Figure Global Pharmacy Revenue and Growth Rate (2017-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue by Regions (2017-2019)
Figure North America Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure North America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2019)
Figure North America Inflammatory Bowel Disease Therapy by Countries (2017-2019)
Figure North America Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2019)
Figure United States Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure United States Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Canada Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Mexico Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Europe Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2019)
Figure Europe Inflammatory Bowel Disease Therapy by Countries (2017-2019)
Figure Europe Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Germany Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Germany Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure France Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure UK Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Russia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Italy Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Rest of Europe Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy by Countries (2017-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2019)
Figure China Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure China Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Japan Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Korea Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure India Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure South America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2019)
Figure South America Inflammatory Bowel Disease Therapy by Countries (2017-2019)
Figure South America Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Brazil Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Argentina Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Columbia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Rest of South America Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy by Countries (2017-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Saudi Arabia Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure United Arab Emirates Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Egypt Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Nigeria Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure South Africa Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Turkey Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Laboratories Inflammatory Bowel Disease Therapy Financial Overview
Table Valeant Pharmaceuticals International Inflammatory Bowel Disease Therapy Financial Overview
Table Novartis AG Inflammatory Bowel Disease Therapy Financial Overview
Table Janssen Biotech, Inc. Inflammatory Bowel Disease Therapy Financial Overview
Table Alkem Laboratories Limited Inflammatory Bowel Disease Therapy Financial Overview
Table AbbVie, Inc. Inflammatory Bowel Disease Therapy Financial Overview
Table UCB Inc Inflammatory Bowel Disease Therapy Financial Overview
Table Takeda Pharmaceutical Company Limited Inflammatory Bowel Disease Therapy Financial Overview
Table Biogen Inc. Inflammatory Bowel Disease Therapy Financial Overview
Table Pfizer Inc. Inflammatory Bowel Disease Therapy Financial Overview
Figure Global Inflammatory Bowel Disease Therapy Revenue (Millions USD) and Growth Rate (2019-2027)
Table Inflammatory Bowel Disease Therapy Market Forecast by Regions (2019-2027)
Figure North America Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure United States Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Canada Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Mexico Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Europe Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Germany Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure France Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure UK Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Russia Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Italy Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Rest of Europe Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure China Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Japan Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Korea Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure India Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure South America Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Brazil Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Argentina Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Columbia Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Rest of South America Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Saudi Arabia Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure United Arab Emirates Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Egypt Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Nigeria Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure South Africa Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Turkey Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Inflammatory Bowel Disease Therapy Market Forecast (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Forecast by Type (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Market Share Forecast by Type (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Forecast by Type (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Forecast by Applications (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Market Share Forecast by Applications (2019-2027)
Figure Global Inflammatory Bowel Disease Therapy Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|